Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination
SDS Optic’s inPROBE® marks a pivotal shift in oncology towards personalized medicine, particularly in the assessment of protein expression like HER2.
- SDS Optic’s inPROBE® marks a pivotal shift in oncology towards personalized medicine, particularly in the assessment of protein expression like HER2.
- This novel in vivo approach allows the examination with optic fiber probe directly in the patient’s body without tissue extraction.
- These outcomes have paved the way for further research across different cancers and other diseases where protein markers are critical.
- inPROBE® not only enhances the accuracy of cancer diagnostics and treatment but also holds potential for broader scientific and industrial applications.